[1] 尹雄章,杜 光,孙明辉.磷霉素的作用机制及临床应用[J].医药导报,2011,30(12):1608-1613.
[2] 徐锦霞,赵 银,赵玉兰.磷霉素治疗临床耐药菌感染[J].中国医院药学杂志,2001,21(8):480-482.
[3] Takahata S,Ida T,Hiraishi T,et al.Molecular mechanisms of fosfomycin resistance in clinical isolates of Esherichia coli[J].Int J Antimicrob Agents,2010,35(4):333-337.
[4] Wachino J,Yamane K,Suzuki S,et al.Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes[J].Antimicrob Agents Chemother,2010,54(7):3061-3064.
[5] Hou J,Huang X,Deng Y,et al.Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFⅡ plasmids among Escherichia coli isolates from pets in China[J].Antimicrob Agents Chemother,2012,56(4):2135-2138.
[6] Hemaiswarya S,Kruthiventi A K,Doble M.Synergism between natural products and antibiotics against infectious diseases[J].Phytomedicine,2008,15(8):639-652.
[7] 杭永付,薛晓燕,方 芸,等.中药抗菌和逆转耐药作用机制研究进展[J].中国药房,2011,22(47):4504-4507.
[8] Petersen M,Monique S J S.Rosmarinic acid[J].Phytochemistry,2003,62(2):121-125.
[9] 张致平.微生物药物学[M].北京:化学工业出版社,2004.
[10] 赵 波,李 波,王 强,等.4个动物园灵长类动物肠道克雷伯氏菌的分离鉴定与药敏试验[J].中国畜牧兽医,2013,40(2):161-165.
[11] 苑 丽,刘建华,胡功政,等.30株鸡大肠杆菌ESBLs 基因型检测鸡耐药性分析[J].中国预防兽医学报,2009,31(6):438-442.
[12] 马绪荣,苏德模.药品微生物学检验手册[M].北京:科学出版社,2001.
[13] 刘 波,李雪驼,徐和利,等.5种中药制剂杀灭幽门螺杆菌的实验研究[J].中国新药杂志,2002,6(11):457-459.
[14] Clinical and Laboratory Standards Institute.Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals-third edition:Approved standard M31-A3[S].CLSI,Wayne,PA,USA,2008.
[15] 郝 刚.BuforinⅡ抗菌肽的分子设计及对DNA作用抑菌机理研究[D].无锡:江南大学,2009.
[16] Lin E,Stanek R J,Mufson M A.Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro[J].Antimicrob Agents Chemother,2003,47(3):1151-1153.
[17] Liu Y X,Ji Z Z.Progress in the pharmacological research on rosmarinic acid[J].World Phar Plant Drug Fascicule,1993,8(5):248-251.
[18] Neusal F,Sara Raquelm M A,Pedro L F,et al.The inhibitory effect of Plectranthus barbatus and Plectranthus ecklonii leaves on the viability,glucosyl transferase activity and biofilm formation of Streptococcus sobrinus and Streptococcus mutans[J].Food Chem,2010,119(2):664-668.
[19] Borkowski B,Biesiadecka A,Litwinska B.Comparison of the antiviral activity of caffeic,chlorogenic androsmarinic acid[J].Herba Pol,1996,42(3):317-321.
[20] Osakabe N,Yasuda A,Natsume M,et al.Rosmarinic acid inhibits epidermal inflammatory responses:Anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model[J]. Carcinogenesis,2004,2(4):549-557.
[21] Kim J H,Lee B J,Kim J H,et al.Rosmarinic acid suppresses retinal neovas cularization via cell cycle arrest with increase of p21WAF1 expression[J].Eur J Pharmacol,2009,615(1-3):150-154.
[22] Ito N,Yabe T,Gamo Y,et al.Rosmarinic acid from Perillae Herba produces an antidepressant-like effect in mice through cell proliferation in the hippocampus[J].Bio Pharm Bull,2008,31(7):1376-1380.
[23] Baba S,Osakabe N,Natsume M,et al.Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma,and is degraded and metabolized to conjugated forms of caffeic acid,ferulic acid and m-coumaric acid[J].Life Sci,2004,75(2):165-178.
[24] Baba S,Osakabe N,Natsume M,et al.Absorption,metabolism,degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans[J].Eur J Nutr,2005,44(1):1-9.
[25] 李 妍,郭琼杰,孙淑娟.抗真菌药物联合应用的体外药效评价方法[J].抗感染学,2007,4(2):51-55. |
